The Enhanced Pharmacological Effects of Modified Traditional Chinese Medicine in Attenuation of Atherosclerosis Is Driven by Modulation of Gut Microbiota
Accumulating evidence indicated that gut microbiota-targeted therapy is a promising strategy to treat Cardiovascular Disease (CVD). Traditional Chinese Medicine (TCM) has been used in CVD treatments for over 2,000 years which is believed to result from the modulation of gut microbiota, yet the under...
Main Authors: | Wenyan Ji, Ting Jiang, Zheng Sun, Fei Teng, Chenchen Ma, Shi Huang, Suhua Yan |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-10-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2020.546589/full |
Similar Items
-
Alisma orientalis Beverage Treats Atherosclerosis by Regulating Gut Microbiota in ApoE-/- Mice
by: Boran Zhu, et al.
Published: (2020-09-01) -
An investigation Into Traditional Chinese Medicine Hospitals in China: Development Trend and Medical Service Innovation
by: Liang Wang, et al.
Published: (2017-01-01) -
Gut microbiota as a target to limit toxic effects of traditional Chinese medicine: Implications for therapy
by: Wuwen Feng, et al.
Published: (2021-01-01) -
Utilization of Traditional Chinese Medicine Practitioners in Later Life in Mainland China
by: Jessica Yi Han Aw, et al.
Published: (2019-08-01) -
Anticancer activities of TCM and their active components against tumor metastasis
by: Kailong Wang, et al.
Published: (2021-01-01)